Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 102201
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102201
Table 3 The cumulative recurrence rates and overall survival rates of 181 advanced gastric cancer patients undergoing gastrectomy and prophylactic hyperthermic intraperitoneal chemotherapy
Rates
1 year
2 years
3 years
Median OS
Overall survival rates96.1%75.1%53.6%41.3 months